Drugs / Sennoside
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00902031 Background | Apr 2006 → Oct 2010 | constipation disorder | University of Alberta | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sennoside | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00902031 ↗ |
| Route | Oral | “Sennoside: will be given in tablet form (8.6 mg), 1-3 tablets taken 1-3 times daily for 10 days.” NCT00902031 ↗ |